Skip to main content

Advertisement

Table 3 Antibiotics resistance patterns of GPB, HUCSH, and Southern Ethiopia

From: The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years’ retrospective study

Antibiotics S. aureus (156) CoNS (64) Enterococcus spp(31) S. pneumoniae (7) Total
R (%) R (%) R (%) R (%) R (%)
AMP NR NR 20(74.1) NR 20(74.1)
GEN 42(31.8) 32(55.2) NR NR 74(38.9)
COT 61(73.5) 49(90.7) NR 4(66.7) 116(81.1)
PEN 41(80.4) 24(92.3) 6(75) 1(33.3) 72(81.8)
CAF 22(19.5) 22(40.7) 8(34.8) 3(60) 55(28.2)
CLD 2(5.3) ND NR NR 2(5.3)
NOR 15(65.2) 3(33.3) 10(83.3) NR 28(63.6)
NIT 1(14.3) ND 1(12.5) NR 2(13.3)
ERY 20(31.7) 9(50) 11(73.3) 0(0) 40(40.4)
TAT 11(61.1) ND 3(100) 0(0) 14(63.6)
CIP 42(31.8) 27(46.6) 19(76) NR 88(40.9)
AUG 51(52) 24(39.3) NR NR 75(47.2)
CTR 39(45.3) 22(41.5) NR NR 61(43.9)
CAZ 27(58.7) 31(79.5) NR ND 58(68.2)
  1. NR- Not recommended, ND-not done, R-Resistance, T- total tested, CoNS- coagulase-negative staphylococcus, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg), penicillin G-PEN(10 IU), Clindamycin-CLD(2 μg) and erythromycin-ERY(15 μg).